Insulin action in skeletal muscle from patients with NIDDM

Molecular and Cellular Biochemistry

Volumn 182, Issue 1-2, 1998, Pages 153-160

  Zierath, Juleen R ^a   Krook, Anna ^a   Wallberg Henriksson, Harriet ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

GLUT4; Insulin; IRS 1; NIDDM; PI3 kinase; Skeletal muscle

Indexed keywords

3 METHYLGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; CELL MEMBRANE; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE;

DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION;

EID: 0031896056     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006861628496     Document Type: Article

References (65)

1. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329: 1988-1992, 1993
2. Turner RC, Hattersley AT, Shaw JTE, Levy JC: Type II diabetes: clinical aspects of molecular biological studies. Diabetes 44: 1-10, 1995
3. Porte Jr D: β-cells in Type II diabetes mellitus. Diabetes 40: 166-180, 1991
4. DeFronzo RA: The triumvirate: β-cell, muscle or liver. A collusion responsible for NIDDM. Diabetes 37: 667-687, 1988
5. Zierath JR, He L, Gumá A, Odegaard-Wahlström E, Klip A, Wallberg-Henriksson H: Insulin action on glucose transport and plasma membrane content in skeletal muscle from patients with NIDDM. Diabetologia 39:1180-1189, 1996
6. Kelley DE, Mokan M, Mandarino LJ: Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients. Diabetes Care 16: 1158-1166, 1993
7. Efendic S, Östenson CG: Hormonal responses and future treatment of non-insulin-dependent diabetes mellitus (NIDDM). J Internal Med 234: 127-138, 1993
8. Efendic S, Kahn A, Östenson CG: Insulin release in Type 2 diabetes mellitus. Diabete et Metabolisme 20: 81-86, 1994
9. Galuska D, Nolte LA, Zierath JR, Wallberg-Henriksson H: Effect of metformin on insulin-stimulated glucose transport in isolated muscle obtained from patients with NIDDM. Diabetologia 37: 826-832, 1994
10. Laws A, Stefanick ML, Reaven, GM: Insulin resistance and hypertriglygeridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69: 343-347, 1989
11. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 89: 782-788, 1992
12. Eriksson J, Koranyi L, Bourey R, Schalin C, Widén E, Mueckler M, Permutt AM, Groop LC: Insulin resistance in type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT4) gene in human skeletal muscle. Diabetologia 35: 143-147, 1992
13. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929, 1992
14. Seals DR, Hagberg JM, Allen WK, Hurley BF, Dalsky GP, Ehsani AA, Holloszy JO: Glucose tolerance in young and older athletes and sedentary men. J Appl Physiol 56: 1521-1525, 1984
15. Friedman JE, Dohm GL, Leggett-Frazier, N, Elton CW, Tapscott EB, Pories WP, Caro JF: Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. J Clin Invest 89: 701-705, 1992
16. DeFronzo RA, Gunnarsson R, Björkman O, Olsson M., Wahren J: Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (Type II) diabetes mellitus. J Clin Invest 76: 149-155, 1985
17. Eriksson E, Franssila-Kallunki A, Ekstrand A et al.: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Eng J Med 321: 337-343, 1989
18. 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223-228, 1990
19. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-1007, 1981
20. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teriis M, Haaparanta M, Bergman J, Solin O, Viopio-Pulkki L-M, Wegelius U, Yki-Jaryinen H: Glucose free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89: 1767-1774, 1992
21. Thiebaud D, Jacot E, DeFronzo RA, Maeder E, Jequier E, Felber JP: The effect of graded doses of insulin on total glucose uptake, glucose oxidation and glucose storage in man. Diabetes 31: 957-963, 1982
22. Kelley DE, Mandarine LJ: Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin dependent diabetes mellitus. J Clin Invest 86: 1999-2007, 1990
23. Vaag A, Damsbo P, Hother-Nielsen O, Beck-Nielsen H: Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 80-88, 1992
24. Zierath JR, Galuska D, Nolte LA, Thörne A, Smedegaard Kristensen J, Wallberg-Henriksson H: Effects of glycemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetoliga 37: 270-277, 1994
25. Andréasson K, Galuska D, Thörne A, Sonnenfeld T, Wallberg-Henriksson H: Decreased insulin-stimulated 3-O-methylglucose transport in in vitro incubated muscle strips from type II diabetic subjects. Acta Physiol Scand 142: 255-260, 1991
26. Bonadonna RC, Del Prato S, Saccomani MP, Bonora E, Gulli G, Ferrannini E, Bier D, Cobelli C, DeFronzo RA: Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest 92: 486-494, 1993
27. Zierath JR: In vitro studies of human skeletal muscle: Hormonal and metabolic regulation of glucose transport. Acta Physiol Scand 155 (Suppl. 626): 1-96, 1995
28. Saad MJA, Araki E, Miralpeix M, Rothenberg PL, White MF, Kahn CR: Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance. J Clin Invest 90: 1839-1849, 1992
29. Folli F, Saad MJA, Backer JM, Kahn CR: Regulation of phosphatidyl-inositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin deficient diabetes mellitus. J Clin Invest 92: 1787-1794, 1993
30. Saad MJA, Folli F, Kahn JA, Kahn CR: Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. J Clin Invest 92: 2065-2072, 1993
31. Heydrick SJ, Jullien D, Gautier N, Tanti JF, Giorgetti S, Van Obberghen E, Marchand-Brustel Y: Defect in skeletal muscle phosphatidyl-inositol-3-kinase in obese insulin-resistant mice. J Clin Invest 91: 1358-1366, 1993
32. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL: Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95: 2195-2204, 1995
33. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spegelman BM: IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and Obesity-induced insulin resistance. Science: 271: 665-668, 1996
34. Wallberg-Henriksson H, Zetan N, Henriksson J: Reversibility of decreased insulin-stimulated glucose transport capacity in diabetic muscle with in vitro incubation: insulin is not required. J Biol Chem 262: 7665-7671, 1987
35. Nolan JJ, Freidenberg G, Henery R, Reichart D, Olefsky JM: Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 78: 471-477, 1994
36. Grasso G, Frittitta L, Anello M, Russo P, Sesti O, Trsichitta V: Insulin receptor tyrosine kinase activity is altered in both muscle and adipose tissue from non-obese normoglycaemic insulin-resistant subjects. Diabetologia 38: 55-61, 1995
37. Maegawa H, Shigeta Y, Egawa K, Kobayashi M: Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 40: 815-819, 1991
38. Björnholm M, Kawano Y, Lehtihet M, Zierath JR: Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 406: 524-527, 1997
39. Hitman GA, Hawrami K, McCarthy MI, Viswanathan M, Snehalatha C, Ramachandran A, Tuomilehto J, TuomilehtoWolf E, Nisinen A, Pedersen O: Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease. Diabetologia 38: 481-486, 1995
40. Imai Y Fusco A, Suzuki Y, Lesniak MA, DAlfonso R, Sesti G, Bertoli A, Lauro R, Accili D, Taylor SI: Variant sequences of insulin receptor substrate-1 in patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 79: 1655-1658, 1994
41. Almind K, Bjørbæk C, Vestergaard H, Hansen T, Echwald S, Pedersen: Amino acid polymorphisms of insulin receptor substrate-1 in noninsulin-dependent diabetes mellitus. The Lancet 342: 828-832, 1993
42. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS: Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94:1141-1146, 1994
43. Shepherd PR, Nave BT, Rincon J, Nolte LA, Bevan AP, Siddle K, Zierath JR, Wallberg-Henriksson H: Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human skeletal muscle. J Biol Chem 272: 19000-19007, 1997
44. Bjørbæk C, Echwald SM, Hubricht P, Vestergaard H, Hansen T, Zierath J, Pedersen O: Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM. Diabetes 43: 976-983, 1994
45. Choi W-H, O'Rahilly S, Buse JB, Rees A, Morgan R, Flier JS, Moller DE: Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects. Diabetes 40: 1712-1718, 1991
46. O'Rahilly S, Krook A. Morgan R, Rees A, Flier JS, Moller DE: Insulin receptor and insulin-responsive glucose transporter (GLUT4) mutations and polymorphisms in a Welsh type 2 (non-insulin-dependent) diabetic population. Diabetologia 35: 486-489, 1992
47. Garvey WT, Maianu L, Hueeksteadt TP, Bimbaum MJ, Molina JM, Ciaraldi TP: Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with noninsulin-dependent diabetes mellitus and obesity. J Clin Invest 87: 1072-1081, 1991
48. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn, BB: Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865-870, 1990
49. Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J: Expression of insulin regulatable glucose transporters in skeletal muscle from Type 2 (non-insulin dependent) diabetic patients. Diabetologia 33: 625-627, 1990
50. Garvey WT, Maianu L, Hancock JA, Golichowski AM, Baron A: Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM. Diabetes 41: 465-475, 1992
51. Andersen PH, Lund S, Vestergaard H, Junker S, Kahn BB, Pedersen O: Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion. J Clin Endocrinol Metab 77: 27-32, 1993
52. Schalin-Jäntti C, Yki-Järvinen H, Koranyi L, Bourey R, Lindström J, Nikula-Ijäs P, Franssila-Kallunki A, Groop LC: Effect of insulin on GLUT4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives. Diabetologia 37: 401-407, 1994
53. Gumá A, Zierath JR, Wallberg-Henriksson H, Klip A: Insulin induces translocation of GLUT-4 glucose transporters in human skeletal muscle. Am J Physiol 268: E613-E622, 1995
54. Lund S, Holman GD, Zierath JR, Rincon J, Nolte LA, Clark AE, Pedersen O, Wallberg-Henriksson H: Effect of insulin on GLUT4 translocation and turnover rate in human skeletal muscle as measured by the exofacial bismannose photolabeling technique. Diabetes 46: 1965-1969, 1997
55. Postic C, Leturque A, Printz RL, Maulard P, Loizeau M, Granner DK, Girard J: Development and regulation of glucose transporter and hexokinase expression in rat. Am J Physiol 266: E548-E559, 1994
56. 31P Nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J Clin Invest 89: 1062-1075, 1992
57. Printz RL, Ardehali H, Koch S, Granner DK: Human hexokinase II mRNA and gene structure. Diabetes 44: 290-294, 1995
58. Echwald SM, Bjørbæk C, Hansen T, Clausen JO, Vestergaard H, Zierath JR, Printz RL, Granner DK, Pedersen O : Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity. Diabetes 44: 347-353, 1995
59. Laakso M, Malkki M, Deeb SS: Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes 44: 330-334, 1995
60. 142→His substitution. Diabetes 44: 340-346, 1995
61. Bogardus C, Lillioja S, Stone K, Mott D: Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest 73: 1185-1190, 1984
62. Roch-Noriand AE, Bergström J, Hultman E: Muscle glycogen and glycogen synthase in normal subjects and in patients with diabetes mellitus: effect of intravenous glucose and insulin administration. Scan J Clin Invest 30: 77-84, 1972
63. Vestergaard H, Bjørbæk C, Andersen PH, Bak JF, Pedersen O: Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients. Diabetes 40: 1740-1745, 1991
64. Bjørbæk C, Vik TA, Echwald SM, Yang P-Y, Vestergaard H, Wang JP, Webb GC, Richmond K, Hansen T, Erikson RL, Miklos GLG, Cohen PTW, Pedersen O: Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients. Diabetes 44: 90-97, 1995
65. Beck-Nielsen H, Hother-Nielsen O, Vaag A, Alford F: Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycemia. A critical comment. Diabetologia 37: 217-221, 1994